News – Page 525 – Endpoints News

Icahn School of Medicine, RPI launch new institute focused on engineering and precision medicine

4 years ago

Jubilant HollisterStier nets US government contract to increase activity at its growing facility

4 years ago

J&J takes Aurobindo to court over potential Erleada generic

4 years ago

Pharma mergers: FTC and DOJ to explore new ways of enforcing antitrust laws

4 years ago

Novartis' Sandoz founds new initiative to expand biosimilar use more globally

4 years ago

Another 14 generics threaten Eli Lilly's blockbuster chemotherapy Alimta

4 years ago

MarketingRx roundup: Novartis cooks up promo with celeb chef; Pharmas launch annual ASCO social media blitz

4 years ago

Research revamp: UK calls on clinical trial sponsors to shut down trials that aren't viable

4 years ago

Medicare doesn't reduce its 2022 premium hike even as use of Biogen's Alzheimer's drug is sharply curtailed

4 years ago

Speaking of the future: Amazon Alexa and the voice-enabled app market for pharma and healthcare

4 years ago

Peptide biotech gets renewed support from Bristol Myers, others to bankroll multiple oncology clinical programs

4 years ago

Covid-19 roundup: Moderna reclaims vaccine marketing rights in Japan; New IP waiver draft

4 years ago

Swedish biotech crumbles in face of PhII failure of prostate cancer vaccine

4 years ago

Will third time be the charm? Lexicon finally refiles SGLT2 drug for heart failure

4 years ago

Microcap's effort to take on Eylea with Avastin biosimilar faces significant FDA roadblock

4 years ago

Once again, the FDA is delaying BioMarin’s hemophilia A quest as gene therapy frets simmer

4 years ago

TG Therapeutics gets 3-month punt from FDA for standalone BLA in aftermath of Ukoniq + adcomm withdrawal

4 years ago

Sanofi's big plans for Cialis OTC launch run into a red light at the FDA

4 years ago

Former AstraZeneca exec committed insider trading on landmark 2019 Enhertu deal, SEC alleges

4 years ago

Roche wins new Evrysdi approval for the youngest SMA patients

4 years ago

Long after the blockbuster shoutouts faded to a whisper, TherapeuticsMD gets an M&A deal

4 years ago

GSK bets $3.3B on a buyout, jumping into a blockbuster showdown with Pfizer and Merck

4 years ago

Biomarker 'roadmaps' and the future of cancer R&D; Curtain raises on #ASCO22; Pfizer, Novartis tackle drug access; ...

4 years ago

GSK's ViiV debuts next evolution in HIV med Dovato campaign with new spokespeople and new message

4 years ago

First page Previous page 522 523 524525526 527 528 Next page Last page